Real-world use of novel β-lactams in immunologically vulnerable patients: insights from an Italian retrospective cohort
- DOI
- 10.1093/jacamr/dlag171
- Published
- 2026-07-02
- Container
- JAC-Antimicrobial Resistance
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/jacamr/dlag171,
title = {Real-world use of novel β-lactams in immunologically vulnerable patients: insights from an Italian retrospective cohort},
author = {Matilde Bognetti and Federico Fama and Claudia Conflitti and Fabio Brivio and Marco Piscaglia and Monica Schiavini and Maria Vittoria Cossu and Stefania Vimercati and Elisabetta Rossin and Teresa De Falco and Cristina Pagani and Sara Giordana Rimoldi and Andrea Gori and Marta Colaneri and Emanuele Palomba},
year = {2026},
journal = {JAC-Antimicrobial Resistance},
doi = {10.1093/jacamr/dlag171},
url = {https://doi.org/10.1093/jacamr/dlag171}
}RIS
TY - JOUR TI - Real-world use of novel β-lactams in immunologically vulnerable patients: insights from an Italian retrospective cohort AU - Matilde Bognetti AU - Federico Fama AU - Claudia Conflitti AU - Fabio Brivio AU - Marco Piscaglia AU - Monica Schiavini AU - Maria Vittoria Cossu AU - Stefania Vimercati AU - Elisabetta Rossin AU - Teresa De Falco AU - Cristina Pagani AU - Sara Giordana Rimoldi AU - Andrea Gori AU - Marta Colaneri AU - Emanuele Palomba PY - 2026 JO - JAC-Antimicrobial Resistance DO - 10.1093/jacamr/dlag171 UR - https://doi.org/10.1093/jacamr/dlag171 ER -
APA
Bognetti, M., Fama, F., Conflitti, C., Brivio, F., Piscaglia, M., Schiavini, M., Cossu, M. V., Vimercati, S., Rossin, E., Falco, T. D., Pagani, C., Rimoldi, S. G., Gori, A., Colaneri, M., & Palomba, E. (2026). Real-world use of novel β-lactams in immunologically vulnerable patients: insights from an Italian retrospective cohort. JAC-Antimicrobial Resistance. https://doi.org/10.1093/jacamr/dlag171
Source records
- crossref · retrieved 2026-09-27T00:19:57.749Z